Cargando…
The post-Theranos world
Advances in technology and changes to healthcare during the pandemic may finally realize the vision of patient-centric blood testing espoused by disgraced Theranos CEO Elizabeth Holmes.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106795/ https://www.ncbi.nlm.nih.gov/pubmed/35136231 http://dx.doi.org/10.1038/s41587-022-01242-0 |
Ejemplares similares
-
Theranos and the scientific community: at the bleeding edge
por: The Lancet
Publicado: (2022) -
Lessons from Theranos – Restructuring Biomedical Innovation
por: Das, Rishub Karan, et al.
Publicado: (2022) -
Startup Ethics: Ethically Responsible Conduct of Scientists and Engineers at Theranos
por: McGinn, Robert E.
Publicado: (2022) -
New Insight into Mechanisms of Cardiovascular Diseases: An Integrative Analysis Approach to Identify TheranoMiRNAs
por: Sessa, Francesco, et al.
Publicado: (2023) -
Fake It Till You Make It: What Every Translational Investigator Can Learn From the Rise and Fall of Theranos
por: Mann, Douglas L.
Publicado: (2022)